Cargando…
Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1)
BACKGROUND: Treatment decisions in prostate cancer (PCa) rely on disease stratification between localised and metastatic stages, but current imaging staging technologies are not sensitive to micro-metastatic disease. Circulating tumour cells (CTCs) status is a promising tool in this regard. The Pars...
Autores principales: | Al-Hammouri, Tarek, Almeida-Magana, Ricardo, Lawrence, Rachel, Duffy, Tom, White, Laura, Burke, Edwina, Kudahetti, Sakunthala, Collins, Justin, Rajan, Prabhakar, Berney, Daniel, Gabe, Rhian, Shaw, Greg, Lu, Yong-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288675/ https://www.ncbi.nlm.nih.gov/pubmed/37353740 http://dx.doi.org/10.1186/s12885-023-11081-0 |
Ejemplares similares
-
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
por: Davies, Caitlin R., et al.
Publicado: (2023) -
Surgical Techniques to Optimize Early Urinary Continence Recovery Post Robot Assisted Radical Prostatectomy for Prostate Cancer
por: Sridhar, Ashwin N., et al.
Publicado: (2017) -
Radical retropubic and perineal prostatectomy for clinically localised prostate cancer in renal transplant recipients
por: Heidenreich, Axel, et al.
Publicado: (2014) -
Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy
por: Grogg, Josias Bastian, et al.
Publicado: (2023) -
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing
por: Guo, Tianyu, et al.
Publicado: (2021)